21022 Federal Register / Vol. 72, No. 81 / Friday April 27, 2007 / Notices 

Dated: April 23, 2007. 

Joan F. Karr, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E7–8073 Filed 4–26–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–07–07AY] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 and 

send comments to Joan Karr, CDC 

Acting Reports Clearance Officer, 1600 

Clifton Road, MS–D74, Atlanta, GA 

30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Long-Term Efficacy of a Program to 

Prevent Beryllium Disease—New—

National Institute for Occupational 

Safety and Health (NIOSH), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

Beryllium is a lightweight metal with 

many applications. Exposed workers 

may be found in the primary 

production, nuclear power and 

weapons, aerospace, scrap metal 

reclamation, specialty ceramics, and 

electronics industries, among others. 

The size of the USA workforce at risk 

of chronic beryllium disease (CBD), 

from either current or past work-related 

exposure to the metal, may be as high 

as one million. Demand for beryllium is 

growing worldwide, which means that 

increasing numbers of workers are likely 

to be exposed. 

Exposure to beryllium can lead to 

sensitization and cause an immunologic 

granulomatous lung disease. 

Sensitization is a cell-mediated allergictype response that may be detected in 

the peripheral blood with the beryllium 

lymphocyte proliferation test (BeLPT), 

which is used by the industry as a 

surveillance tool. Workers found to be 

sensitized may be clinically evaluated 

for CBD with tests including 

bronchoalveolar lavage and 

transbronchial biopsy. Cross-sectional 

studies in various beryllium workplace 

populations have identified 

sensitization in the range of less than 

1% to 14% of workers. The proportion 

of sensitized workers who have 

beryllium disease at initial clinical 

evaluation has varied from 10 to 100% 

in different workplaces. Sensitized 

workers not initially diagnosed with 

CBD are often diagnosed with the 

disease upon follow-up, but whether all 

sensitized workers will eventually 

develop beryllium disease is unknown. 

Industry screening programs have 

enabled the identification of CBD in 

persons without apparent symptoms, 

often early in disease progression (often 

referred to as ‘‘subclinical disease’’). 

Progression from sensitization to 

subclinical disease to clinical 

impairment, while difficult to predict 

for any one individual, is not 

uncommon. 

Currently, there are no preventive 

programs that have been demonstrated 

to have long-term effectiveness in 

preventing beryllium sensitization and 

CBD among beryllium-exposed workers. 

In the United States, recent short-term 

evidence (i.e., average work tenure 16 

months, maximum four years) at one 

facility suggests that the comprehensive 

preventive program that was 

implemented by company management 

beginning in 2000 has successfully 

reduced the incidence of beryllium 

sensitization, as defined by the 

occurrence of confirmed abnormal 

BeLPTs. However, the follow-up has 

thus far been limited to current workers, 

the duration has been too short to 

document a reduced incidence of CBD, 

and it is possible that sensitization has 

been delayed, rather than prevented. 

Evaluation of this program’s 

effectiveness would therefore be more 

complete by including individuals who 

have left employment and documenting 

whether: (1) The program was effective 

at two other facilities at which it was 

implemented, (2) the program prevented 

beryllium sensitization over a longer 

period of time (i.e., up to eight years); 

and (3) the program prevented CBD, 

which generally takes longer to develop. 

Study Design 

This proposed study is designed to 

evaluate the effectiveness of a 

comprehensive preventive program at 

three beryllium plants. Eligible workers 

for this survey include those hired 

between implementation of a 

comprehensive program (2000–01) and 

December 31, 2008, including any 

already known to be sensitized. NIOSH 

will offer all eligible current and former 

workers the BeLPT to identify 

sensitization and administer a work and 

medical history questionnaire. 

There are no costs to former worker 

respondents except their time to 

participate in the interview. Current 

workers will participate during work 

hours, and will thus be compensated for 

their time by their employer. Former 

workers will participate during their 

own time. 

ESTIMATE OF ANNUALIZED BURDEN HOURS

Respondents Number of 

respondents 

Number of 

responses/respondent 

Avg. burden/ 

response 

(in hours) 

Total burden 

(in hours) 

Current Workers .............................................................................................. 239 1 45/60 179 

Former Workers ............................................................................................... 340 1 45/60 255 

Total .......................................................................................................... 579 434 


cprice-sewell on PROD1PC66 with NOTICES
Federal Register / Vol. 72, No. 81 / Friday April 27, 2007 / Notices 21023 

Dated: April 23, 2007. 

Joan F. Karr, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E7–8075 Filed 4–26–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Optimal 

Resources and Care for Children With 

Craniofacial Malformations, Request 

for Applications (RFA) DD07–008 and 

Public Health Research Grants on 

Orofacial Clefts and Craniosynostosis, 

RFA DD07–009 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned SEP: 

Time and Date: 1 p.m.–4 p.m., June 4, 2007 

(Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the review, discussion, and 

evaluation of scientific merit of grant 

applications received in response to RFA 

DD07–008, ‘‘Optimal Resources and Care for 

Children with Craniofacial Malformations,’’

and RFA DD07–009, ‘‘Public Health Research 

Grants on Orofacial Clefts and 

Craniosynostosis,’’ RFA DD07–009. 

Contact Person for More Information: 

Maurine Goodman, MA, MPH, Scientific 

Review Administrator, Centers for Disease 

Control and Prevention, 1600 Clifton Road, 

NE., Mailstop D72, Atlanta, GA 30333, 

Telephone 404.639.4737. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: April 20, 2007. 

Elaine L. Baker, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–8074 Filed 4–26–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10108, CMS–

10219, CMS–10097] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS), Department of Health 

and Human Services, is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the Agency’s function; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Medicaid 

Managed Care Regulations for 42 CFR 

438.6, 438.8, 438.10, 438.12, 438.50, 

438.56, 438.102, 438.114, 438.202, 

438.204, 438.206, 438.207, 438.240, 

438.242, 438.402, 438.404, 438.406, 

438.408, 438.410, 438.414, 438.416, 

438.604, 437.710, 438.722, 438.724, and 

438.810; Use: These information 

collection requirements implement 

regulations that allow States greater 

flexibility to implement mandatory 

managed care program, implement new 

beneficiary protections, and eliminate 

certain requirements viewed by State 

agencies as impediments to the growth 

of managed care programs. Information 

collected includes information about 

managed care programs, grievances and 

appeals, enrollment broker contracts, 

and managed care organizational 

capacity to provide health care services. 

Form Number: CMS–10108 (OMB#: 

0938–0920); Frequency: Reporting: 

Occasionally; Affected Public: State, 

Local, or Tribal Government; Number of 

Respondents: 39,114,558; Total Annual 

Responses: 4,640,344; Total Annual 

Hours: 3,930,093.5. 

2. Type of Information Collection 

Request: New collection; Title of 

Information Collection: Health Plan 

Employer Data and Information Set 

(HEDIS); Use: The Centers for 

Medicare & Medicaid Services (CMS) 

collects quality performance measures 

in order to hold the Medicare managed 

care industry accountable for the care 

being delivered, to enable quality 

improvement, and to provide quality 

information to Medicare beneficiaries in 

order to promote an informed choice. It 

is critical to CMS’ mission that we 

collect and disseminate information that 

will help beneficiaries choose among 

health plans, contribute to improved 

quality of care through identification of 

improvement opportunities, and assist 

CMS in carrying out its oversight and 

purchasing responsibilities. 

In December 1997, OMB approved the 

request from CMS for the information 

collections under HEDIS and assigned 

the agency form number CMS–R–200. 

The collections approved under that 

request included the HEDIS collection 

(following the technical specifications 

contained in Volume 2, published by 

the National Committee for Quality 

Assurance (NCQA); the Health of 

Seniors/Health Outcomes Survey (HOS); 

and the Medicare CAHPS survey. 

Since that approval there has been a 

change in the statutory authority as a 

result of the Balanced Budget Act of 

1997. During the latter part of 2000, 

CMS instituted several policy changes 

regarding this collection which reduced 

burden substantially on the part of the 

managed care organizations and the 

process for finalizing and publishing 

that policy delayed the request for OMB 

approval. In addition, the renewal of 

OMB authority for the Medicare CAHPS 

survey was completed as a separate 

request. The HOS renewal was also 

submitted separately. This request is 

solely for the approval of the HEDIS 

collection, which is now a stand alone 

collection. Form Number: CMS–10219 

(OMB#: 0938–NEW); Frequency: Yearly; 

Affected Public: Business or other forprofit and Not-for-profit institutions; 

Number of Respondents: 705; Total 

Annual Responses: 705; Total Annual 

Hours: 33,840. 

3. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Medicare 

Contractor Provider Satisfaction Survey 

(MCPSS); Form No.: CMS–10097 

(OMB#: 0938–0915); Use: The Centers 

for Medicare & Medicaid Services will 

obtain feedback from Medicare 

providers via a survey about 


cprice-sewell on PROD1PC66 with NOTICES